Skip to main content

Table 4 characteristics of radiotherapy plus surgery group and radiotherapy combined with chemotherapy and surgery group after matching

From: Comparison of survival outcomes of locally advanced cervical cancer by histopathological types in the surveillance, epidemiology, and end results (SEER) database: a propensity score matching study

Characteristicsradiotherapy plus surgery CTRT plus surgery 
AC(n = 49)SCC(n = 49)P valueAC(n = 305)SCC(n = 305)P value
age (%)  0.750  0.291
  < 409 (18.4)9 (18.4) 84 (27.5)78 (25.6) 
 40–4917 (34.7)14 (28.6) 101 (33.1)93 (30.5) 
 50–5916 (32.7)15 (30.6) 74 (24.3)95 (31.1) 
 60–697 (14.3)11 (22.4) 46 (15.1)39 (12.8) 
race (%)  1.000  0.56
 Black3 (6.1)3 (6.1) 17 (5.6)16 (5.2) 
 White2 (4.1)2 (4.1) 37 (12.1)29 (9.5) 
 Other44 (89.8)44 (89.8) 251 (82.3)260 (85.2)
grade (%)  0.502  0.927
 I1 (2.0)1 (2.0) 33 (10.8)35 (11.5) 
 II30 (61.2)25 (51.0) 156 (51.1)153 (50.2)
 III17 (34.7)23 (46.9) 109 (35.7)112 (36.7)
 IV1 (2.0)0 (0.0) 7 (2.3)5 (1.6) 
FIGO stage (%)  0.378  0.066
 Ib218 (36.7)17 (34.7) 54 (17.7)34 (11.1) 
 IIa13 (6.1)0 (0.0) 11 (3.6)7 (2.3) 
 IIa24 (8.2)3 (6.1) 19 (6.2)9 (3.0) 
 IIb5 (10.2)12 (24.5) 57 (18.7)60 (19.7) 
 IIIa1 (2.0)1 (2.0) 2 (0.7)2 (0.7) 
 IIIb16 (32.7)15 (30.6) 159 (52.1)190 (62.3)
 IVa2 (4.1)1 (2.0) 3 (1.0)3 (1.0) 
Radiation (%)  0.659  0.988
 Beam radiation34 (69.4)34 (69.4) 145 (47.5)144 (47.2)
 brachytherapy11 (22.4)13 (26.5) 136 (44.6)136 (44.6)
 BRB4 (8.2)2 (4.1) 24 (7.9)25 (8.2) 
status (%)  1.000   
 alive40 (81.6)40 (81.6) 234 (76.7)236 (77.4)0.923
 dead9(18.4)9(18.4) 71(23.3)69(22.6) 
time (mean (SD))37.9 (22.0)39.4(22.1)0.74937.3 (20.6)37.4(21.0)0.939
  1. AC adenocarcinoma, SCC Squamous cell carcinoma, FIGO the International Federation of Gynecology and Obstetrics, BRB Combination of beam with brachytherapy. CTRT radiotherapy combined with chemotherapy, grade I Well differentiated,gradeII Moderately differentiated,gradeIII Poorly differentiated,gradeIV Undifferentiated;SD Standard Deviation